The Competition and Markets Authority (CMA) also fined Flynn Pharma 5.2 million pounds for overcharging for phenytoin sodium capsules, following a dramatic price hike in 2012. (fortune.com)
The Competition Appeal Tribunal (Peter Freeman QC) has rejected an urgent application by Flynn Pharma for interim relief against the CMA's decision that Flynn should reduce its prices of Phenytoin capsules with effect from Monday. (monckton.com)
In the case of phenytoin sodium capsules, the U.K. price charged for 100 mg packs of the drug jumped from 2.83 pounds to 67.50 in 2012, before reducing to 54.00 from May 2014. (fortune.com)